Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

IDRA 4.05 -0.07 (-1.70%)
price chart
Idera Pharmaceuticals Going Into 2015 (IDRA)
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is set to enter 2015 with a number of important developments happening during the year.
Related articles »  
Idera Pharmaceuticals (IDRA) Marked As A Dead Cat Bounce Stock
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Stock to Watch: Idera Pharmaceuticals Inc (NASDAQ:IDRA)  Markets Wired
Should You Invest In FuelCell Energy Inc (FCEL), Idera Pharmaceuticals Inc ...  GSPInsider
Related articles »  
Idera Pharmaceuticals: A Star In The Making (IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is a biotechnology company engaged in discovering and developing Toll-Like Receptors (TLRs) antagonists, novel-synthetic DNA and RNA based drug candidates.
Related articles »  
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Top Pick at Piper Jaffray
[The Fly] Piper Jaffray calls Idera Pharmaceuticals Inc (NASDAQ:IDRA) a top small cap pick for 2015 and reiterates an Overweight rating on the name with a $7 price target.
Idera Pharmaceuticals Director Youssef El Zein Sells 100000 Shares (IDRA)  Ticker Report
News Review -Idera Pharmaceuticals (IDRA),Cosan (CZZ),Hersha Hospitality ...  Techsonian (press release)
Related articles »  
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced after markets closed Tuesday that its immunotherapy intratumoral injection candidate, IMO-2055, showed anti-tumor activity in combination with Bristol-Myers Squibb Co's (NYSE:BMY) Yervoy against a ...
Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With ...  MarketWatch
Related articles »  
Idera Pharmaceuticals Inc.: Idera Pharmaceuticals Names Vincent J. Milano ...
CAMBRIDGE, Mass., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for cancers and rare diseases, announced that it has appointed Vincent ...
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) is Top Small-Cap Star for December 8
Idera Pharmaceuticals Inc. gained 9.16% to $4.41 a share. The gains came on a volume of 4,661,050 shares against an average daily volume of 1,395,849 shares.
Related articles »  
Healthcare Sector Movers: Progenics Pharmaceuticals, Inc. (PGNX), Idera ...
In the Healthcare today Progenics Pharmaceuticals, Inc. (PGNX) has moved with a change from open of .42% at mid-day today with a volume of 666,145 shares.
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) Leads Small-Cap Stars in Early Trading for ...
Equities.com created the Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, to help investors identify those small-cap companies with the most fundamental strength and the best chance for future success.
Related articles »  
Stock Insights on Idera Pharmaceuticals Inc (NASDAQ:IDRA)
[AP] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (Trend Analysis) reported a loss of $9.5 million, or 11 cents per share, in its third quarter.
HealthCare Sector Gainers: Idera Pharmaceuticals Inc (IDRA), Rigel ...  Street Register
Related articles »